欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/1469/003
药品名称Remifentanil Fresenius Kabi 5 mg, powder for concentrate for solution for injection or infusion
活性成分
    • remifentanil 5.0 mg
剂型Powder for concentrate for solution for injection/infusion
上市许可持有人Fresenius Kabi Nederland BV Molenberglei 7 2627 Schelle Belgium
参考成员国 - 产品名称Netherlands (NL)
Remifentanil Fresenius Kabi 5 mg
互认成员国 - 产品名称
    • Germany (DE)
      Remifentanil Kabi 5 mg Pulver zur Herstellung eines Konzentrates zur Herst. e. Inj.- oder Inf.lsg.
    • Denmark (DK)
      Remifentanil "Fresenius Kabi"
    • Belgium (BE)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Remifentanil Kabi 5 mg Pulver zur Herstellung eines Konzentrats für eine Injektions- oder Infusionsl
    • Portugal (PT)
    • Latvia (LV)
      Remifentanil Kabi 5 mg pulveris injekciju vai infūziju šķīduma koncentrāta pagatavošanai
    • Lithuania (LT)
      Remifentanil Kabi 5 mg milteliai injekcinio ar infuzinio tirpalo koncentratui
    • Estonia (EE)
许可日期2009/09/02
最近更新日期2022/11/16
药物ATC编码
    • N01AH06 remifentanil
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Additional Strength/Form
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase